메뉴 건너뛰기




Volumn 17, Issue 2, 2011, Pages

Leukocytoclastic vasculitis: A rare adverse effect secondary to infliximab

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE; INFLIXIMAB;

EID: 78651314978     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21309     Document Type: Letter
Times cited : (9)

References (8)
  • 1
    • 0038109994 scopus 로고    scopus 로고
    • Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: A prospective cohort study
    • Vermeire S, Norman M, Van Assche G, et al. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology. 2003; 125: 32-39.
    • (2003) Gastroenterology. , vol.125 , pp. 32-39
    • Vermeire, S.1    Norman, M.2    Van Assche, G.3
  • 2
    • 0347991877 scopus 로고    scopus 로고
    • The safety profile of infliximab in patients with Crohn's disease: Mayo Clinic experience in 500 patients
    • Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: Mayo Clinic experience in 500 patients. Gastroenterology. 2004; 126: 19-31.
    • (2004) Gastroenterology. , vol.126 , pp. 19-31
    • Colombel, J.F.1    Loftus, Jr.E.V.2    Tremaine, W.J.3
  • 4
    • 0037018761 scopus 로고    scopus 로고
    • Maintenance infliximab for Crohn's disease: The ACCENT i randomised trial
    • Hanauer BS, Feagan GB, Lichtenstein RG, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002; 359: 1541-1549.
    • (2002) Lancet. , vol.359 , pp. 1541-1549
    • Hanauer, B.S.1    Feagan, G.B.2    Lichtenstein, R.G.3
  • 5
    • 10744221312 scopus 로고    scopus 로고
    • Infliximab maintenance therapy for fistulising Crohn's disease
    • Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulising Crohn's disease. N Engl J Med. 2004; 350: 876-885.
    • (2004) N Engl J Med. , vol.350 , pp. 876-885
    • Sands, B.E.1    Anderson, F.H.2    Bernstein, C.N.3
  • 6
    • 58149375907 scopus 로고    scopus 로고
    • Vasculitis induced by tumor necrosis factor-targeted therapies
    • Ramos-Casals M, Brito-Zeron P, Cuadrado MJ, et al. Vasculitis induced by tumor necrosis factor-targeted therapies. Curr Rheumatol Rep. 2008; 10: 442-448.
    • (2008) Curr Rheumatol Rep. , vol.10 , pp. 442-448
    • Ramos-Casals, M.1    Brito-Zeron, P.2    Cuadrado, M.J.3
  • 7
    • 0037405058 scopus 로고    scopus 로고
    • Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab
    • McIlwain L, D.Carter J, Bin-Sagheer S,. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab. J Clin Gastroenterol. 2003; 36: 411-413.
    • (2003) J Clin Gastroenterol. , vol.36 , pp. 411-413
    • McIlwain, L.1    Carter, D.J.2    Bin-Sagheer, S.3
  • 8
    • 5044237150 scopus 로고    scopus 로고
    • Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents
    • Mohan N, Edwards ET, Cupps TR, et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol. 2004; 31: 1955-1958.
    • (2004) J Rheumatol. , vol.31 , pp. 1955-1958
    • Mohan, N.1    Edwards, E.T.2    Cupps, T.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.